Levocetirizine dihydrochloride/Pseudoephedrine Hydrochloride

盐酸左西替利嗪/盐酸伪麻黄碱

Report date: 2026/03/04 20:01:44

Base Information

Drug NameLevocetirizine dihydrochloride/Pseudoephedrine Hydrochloride
Drug Alias Name盐酸伪麻黄碱/盐酸左西替利嗪pseudoephedrine + levocetirizinePseudoephedrine Hydrochloride/Levocetirizine dihydrochloridelevocetirizine + pseudoephedrineKossak2 +[7] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonists
TargetsHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsRhinitis, AllergicRhinitis
Global Approved IndicationsRhinitis, AllergicRhinitis
Approved Indications in ChinaRhinitis, AllergicRhinitis
Original Approved Country/TerritoryMainland China
Original Approved Date2005/12/30
Country/TerritoryBrazilSouth KoreaMainland China
CombinationsYes Pseudoephedrine HydrochlorideLevocetirizine dihydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co LtdJinling Pharmaceutical Co Ltd Nanjing Jinling Pharmaceutical Factory
Inactive CompaniesEurofarma Laboratorios Sa
Active IndicationsRhinitis, AllergicRhinitis
Inactive IndicationsN/A

Other Information

ATC CodeR01BA52
Related LinksN/A